Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
770 INR | -0.23% | +0.96% | -26.81% |
05-21 | Transcript : Anupam Rasayan India Limited, Q4 2024 Earnings Call, May 21, 2024 | |
05-20 | Anupam Rasayan India's Consolidated Net Profit Declines in Fiscal Q4 | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 62.55 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.81% | 1.01B | C+ | ||
+21.26% | 68.69B | A- | ||
-0.07% | 49.19B | A- | ||
+24.11% | 44.73B | B+ | ||
+30.08% | 28.24B | A- | ||
+7.64% | 19.22B | C+ | ||
+10.10% | 16.68B | B+ | ||
-5.26% | 16.08B | B+ | ||
-23.26% | 15.62B | A- | ||
-18.20% | 13.89B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ANURAS Stock
- Ratings Anupam Rasayan India Limited